SCHEMBL28035117

SCHEMBL28035117

CCOC(=O)Cc1c(Cl)ccc(F)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 4/20 0.44
ALDH1A1 P00352 2/20 0.44
ALOX15 P16050 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 2/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.40
RAB9A P51151 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7880397 0.90 KDM4E (0.48) KDM4ELMNAMEN1KMT2AATM
SCHEMBL16964041 0.84 KMT2A (0.47) KDM4ELMNAMEN1KMT2AATM
SCHEMBL5252336 0.81 KMT2A (0.60) KDM4ELMNAMEN1KMT2AATM
SCHEMBL29943508 0.81 KMT2A (0.60) KDM4ELMNAMEN1KMT2AATM
SCHEMBL14999743 0.80 LMNA (0.42) KDM4ELMNAMEN1KMT2AATM
SCHEMBL16964016 0.79 KDM4E (0.43) KDM4ELMNAMEN1KMT2ATDP1
SCHEMBL1429298 0.78 AKR1B1 (0.55) KDM4ELMNAMEN1KMT2AATM
SCHEMBL7494802 0.77 NLRP3 (0.42) KDM4ELMNAMEN1KMT2AATM
Ammonia Solution, Strong SCHEMBL27532390 0.77 AKR1B1 (0.53) KDM4ELMNAMEN1KMT2AATM
SCHEMBL512637 0.75 KMT2A (0.46) KDM4EMEN1KMT2ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106317024-A Crizotinib intermediate, preparation method and crizotinib preparation method 上海艾康睿医药科技有限公司 2017-01-11 CN disclosed
CN-106047950-A Biological preparation method of (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol 尚科生物医药(上海)有限公司 2016-10-26 CN disclosed
CN-103319311-B The preparation method of Crizotinib intermediate (1S)-1-(the chloro-3-fluorophenyl of 2,6-bis-) ethanol ZHEJIANG JIUZHOU PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2015-09-30 CN disclosed